The Edison Prophecy Review: Is Matt McCall’s Early Opportunities Worth It?

Matt McCall’s new Early Opportunities presentation opens not with a stock chart but with a prophecy from 1915. Thomas Edison, the argument goes, predicted that the soldier of the future would not be a saber-bearing warrior but a “machinist,” a technician who fights with machines instead of rifles. McCall’s case is that Edison’s vision is unfolding in real time, in the form of autonomous drones, guided missiles, and the thermal-imaging cameras that let a machine see a soldier, a truck engine, even a warm rifle barrel in total darkness. The investment hook is a hard calendar date: November 27, when China’s one-year hold on germanium and gallium export controls is scheduled to expire.

Behind the framing sits a real, verifiable company. McCall pitches a small American optics maker he describes as “1/150th the size of Lockheed Martin,” one that holds an exclusive license to manufacture an infrared lens technology the US Navy’s scientists spent 30 years developing. We took the presentation apart, checked every clue against the public record, and read the offer’s fine print. Here is what we found.

The Presenter

Matt McCall is one of the more traveled editors in the financial-newsletter business, and that is worth stating plainly up front. Over the years he has run MegaTrend Investor at Stansberry, Investment Opportunities at InvestorPlace, and now Early Opportunities at Monument Traders Alliance, a new publishing partner after a stretch on his own. The through-line across all of them is the same: he aims to buy smaller, earlier-stage companies built on big investment themes, the kind of names he expects to work over the next few years rather than the next few weeks.

His track record is a genuine mix, which is exactly how it should be presented. Stock Gumshoe’s evidence file on McCall shows his best teaser pick was NVIDIA in 2017, a call that arrived well before the AI boom went mainstream and before the stock compounded into one of the best performers of the era. His worst calls, by the same tracking, include a handful of marijuana stocks in 2018 and 2019, a sector that burned early buyers badly. He also logged one of the more spectacular recent performers in The Metals Company, the undersea miner that rode a critical-materials wave before giving back most of its gains over the past year. None of that is hiding: the good calls and the bad ones sit in the same file, and a review that ignores either half is doing the reader a disservice. We go deeper on his background and method in our Matt McCall profile.

What matters for this pitch is that McCall is applying his usual framework: find a technology trend the government is effectively forcing into existence, then find the small company that supplies it before the demand becomes obvious to everyone else. Whether he has found that company this time is the question the rest of this review tries to answer.

The Big Idea

The pitch is a supply-chain story dressed as a century-old prophecy, and the supply-chain part is the part that deserves the attention.

Military night-vision and thermal-imaging systems have historically required germanium in their lenses. The reason that matters is a geographic choke point: China refines most of the world’s germanium, and since December 2024 it has banned sales of the material to the US military. That ban never lifted. Meanwhile Congress has written the next deadlines into law. Starting in December 2027, the Pentagon is barred from buying Chinese germanium at all, and by 2030 it has to get Chinese optics out of its supply chain entirely. Those dates do not depend on Beijing. They are American law.

McCall’s argument is that defense contractors are choosing their suppliers right now, because once a material is designed into a weapons program it can stay there for decades. And the one company positioned to win that selection is the one that has a germanium-free alternative already in hand. That company is LightPath Technologies, and the technology is a specialty material called BlackDiamond chalcogenide glass.

The glass was invented at the US Naval Research Laboratory, the same laboratory Edison is said to have urged the Navy to create, and the same one whose scientists went on to help build America’s first operational radar and the satellite technology behind GPS. The purpose of the glass is specific: to build a domestic, germanium-free supply chain for thermal imaging. LightPath has held an exclusive license from the Navy to manufacture and sell it since 2021. The material can be heated, stamped directly into precision molds, and pressed out by the thousands, which the pitch says can cut cost by as much as two-thirds. That is the “sphere” Edison references in the presentation: the high-tech infrared lens that lets a drone see in total darkness without a gram of Chinese germanium.

There are actually two companies inside this presentation, a primary pick and a freebie. The primary is LightPath. The freebie is Blue Moon Metals, a gallium story we will get to in a moment. Both rest on the same thesis: the United States is rebuilding a domestic supply chain for the critical materials its weapons depend on, and the small companies holding the strategic assets stand to be the early beneficiaries.

The Key Claims

The central claims, in the presentation’s own words:

“November 27 is approaching fast. If China cuts off the materials the Pentagon needs, this tiny company could be the first place it turns.”

“It’s the only company licensed to manufacture and sell a technology the US Navy’s top scientists spent 30 years making. The Pentagon can’t get this tech anywhere else.”

“The company’s orders roughly tripled in a year, to about $111 million.”

“Two American drone makers invested $8 million of their own money in the company.”

There are two more specifics worth pulling out, because they are the kind of checkable details that separate a real thesis from a story. One: “On September 17th, the military chose this company for a program called CLEAR.” Two: “This company brought in $71 million last year.”

The headline clue is internally consistent. Lockheed Martin trades around $130 billion, so “1/150th the size” works out to roughly $870 million, which matches the “$800 million market cap” the ad cites. That figure was accurate about six weeks ago when the ad was recorded. LightPath has since declined, which means the “tiny company” framing is actually more true today than it was at recording. But that decline cuts both ways, and we will get to it.

The “orders tripled to $111 million” claim checks out, with context. A $111 million backlog is genuinely small in absolute terms. Against roughly $71 million of trailing revenue and a market cap in the low-to-mid hundreds of millions, LightPath trades at around 6 times revenue. That is not expensive for a defense supply-chain story with an exclusive Navy license, but it is not the undiscovered bargain the urgency framing implies either.

The weakest part of the thesis is the “only company that can do this” framing. Teledyne’s FLIR is the dominant supplier in thermal imaging and presumably has its own plan for raw-material challenges. Germanium is also sourced from Belgium and Canada, not only China, so the “China is the only source” construction is an oversimplification. And the November 27 deadline deserves care: the one-year export-control hold was itself a product of trade negotiations, which means it could simply be extended or replaced with a new deal rather than snapping into a clean cutoff that instantly reroutes Pentagon orders to LightPath.

The Free Tickers

Two names are revealed in this presentation, and both are worth knowing. The prices below are the November 16, 2026 close from Polygon, set against the November 11 live-presentation reference prices.

LightPath Technologies (LPTH) is the primary pick. LightPath is a specialty optical materials company based in Orlando, Florida, and it has been moving up the value chain. It bought a company called G5 Infrared, which lets it build complete camera systems rather than just supplying the specialized glass, a move that should carry higher margins. The financial story is improving on several fronts at once: revenue of about $71 million last year, an order backlog of roughly $111 million on a 12-month basis (about $133 million total as of the September quarterly report), gross margins climbing from the low 30s to the low 40s over the past year, and five straight quarters of positive adjusted EBITDA. Ondas Holdings and Unusual Machines, two drone makers, each bought $4 million of shares at $5 a little over a year ago. The stock sits around $6.16 today, down roughly 18% from the $7.52 tease price, with a market cap near $432 million.

Blue Moon Metals (BMM) is the freebie. For viewers who sat through the whole presentation, McCall offers a second idea built on gallium, “the metal that melts in your hand,” which sits inside nearly every LED bulb, smartphone signal, and the Navy’s radar. The United States has produced essentially no gallium domestically since 1987, when a small Utah mine shut down because prices were too low. Blue Moon Metals bought that mine, the Apex germanium-gallium-copper project, from Teck Resources, and Teck took shares in Blue Moon instead of cash. Last month, a Pentagon-backed buyer agreed to purchase Blue Moon shares at a nearly 32% premium to the market price. The stock trades around $3.09, down about 14% from the $3.59 tease price, with a market cap near $334 million.

A caveat on confidence, because we think it matters. These are clue-resolved identifications rather than names McCall simply reads off the screen, the standard result of Stock Gumshoe’s detective work on the tease. The identification of LightPath is a clean, high-confidence match across every clue. Blue Moon’s gallium story is real and the Apex mine is a genuine asset, but Blue Moon is an exploration-stage company with a basket of properties, including a polymetallic zinc-gold-silver-copper deposit in California and the Nussir copper project in Norway. The Pentagon-linked premium purchase is a promising signal, but it is a single transaction, not yet a contract to supply the military at scale.

What You Get

The product being sold is Early Opportunities, Matt McCall’s letter at Monument Traders Alliance. The offer is $1,997 for two years, renewing at the same rate, with a 60-day partial refund if you are dissatisfied, minus a 10% fee.

That is the honest shape of the fine print, and it is worth sitting with the refund term specifically. This is not a no-questions-asked, keep-everything refund of the kind some larger publishers advertise. It is a partial refund, and the 10% fee applies even within the 60-day window. For a two-year commitment at just under two thousand dollars, that is a meaningful difference, and a buyer who changes their mind quickly is still out a few hundred dollars.

What the subscription actually delivers is the service McCall has run under several mastheads: a focus on smaller, earlier-stage companies positioned around big investment themes, with the idea that you buy them before the theme becomes crowded. The letter is aimed at growth investors who are comfortable holding small-cap and micro-cap names through volatility, and who accept that a portfolio built this way will contain real losers alongside the occasional NVIDIA-scale winner. If that describes you, the price is the price. If you want a broader look at the publisher behind the offer, we review Monument Traders Alliance itself in our Monument Traders Alliance review.

Our Take

There is a legitimate, defensible idea here, and it is the supply chain, not the prophecy. Domesticating the materials that go into thermal-imaging systems is a real national-security priority with a hard legal backstop, and LightPath holds a genuine asset in its Navy-licensed, germanium-free glass, plus a credible path toward profitability that is already showing up in the numbers. The gallium freebie is a thoughtful second pick: Blue Moon’s Apex project is the historically significant US gallium-germanium mine, and the Teck share-based deal plus a Pentagon-linked premium purchase are exactly the kind of signals worth flagging.

We also think the presentation gets its sourcing right in a way many do not. The specific clues all resolve cleanly: the Navy license, the $111 million backlog, the $71 million revenue, the two $4 million drone-maker investments, and the CLEAR program selection are all real and verifiable. That is the difference between a pitch you can fact-check and a pitch you have to take on faith, and this one is squarely in the first category.

The things to weigh sit on the other side of the ledger. The “only company that can do this” framing overstates the moat, because FLIR and other incumbent suppliers have their own raw-material strategies and germanium is not exclusively Chinese. The November 27 deadline is presented as a binary cliff, but the export-control hold is a negotiation artifact that can be extended or replaced, and orders do not typically reroute overnight on a calendar date. The dilution is real and under-discussed in the pitch: LightPath financed part of its growth by selling shares, which is a legitimate cost the ad never surfaces, and it is part of why the stock has fallen about 18% since the tease while the company itself has kept improving. And the Edison framing is decorative. It is a clever way to make a thermal-imaging lens sound like a century-old prophecy fulfilled, but it adds nothing to the investment case.

Our recommendation: buy LightPath for the lens technology, the backlog, and the margin improvement if you buy it at all, not for Edison’s prophecy or China’s next move. The November 27 date is best treated as a reason to pay attention, not a reason to buy on a timer. The stock has already given back a lot of its 2025 run, which cuts both ways: it is cheaper than the ad describes, but it is also a reminder that this is a volatile small-cap that is still funding its own growth. Early Opportunities itself is a reasonable fit for a specific reader, someone who wants broad exposure to early-stage themes and is willing to accept the two-year, partial-refund commitment, and a poor fit for anyone who wants a confirmed product before buying the theme. For the wider critical-materials story this pitch sits inside, our MP Materials explainer and our America Reloading teardown on the coming rare-earths ban in defense systems cover the adjacent ground in detail.

Where to Learn More

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.